Literature DB >> 2516778

Percutaneous intravascular biopsy using a Simpson atherectomy catheter: technical note.

F Castaneda1, G Moradian, D Hunter, W Castaneda-Zuniga, K Amplatz.   

Abstract

The design of the Simpson atherectomy catheter makes this device a potentially safe and technically easy tool to obtain adequate pathologic intravascular or intraluminal specimens. The risk of perforation should be low, but this use has to be further studied. We describe the first intravascular biopsy performed with the Simpson catheter.

Mesh：

Year:  1989        PMID： 2516778     DOI： 10.1007/bf02575436

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  4 in total

1.  Percutaneous atherectomy as an alternative treatment for postangioplasty obstructive intimal flaps.

Authors:  M Maynar; R Reyes; V Cabrera; M Roman; J M Pulido; F Castaneda; J G Letourneau; W R Castaneda-Zuniga
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

2.  Benign superior vena cava syndrome.

Authors:  V Mahajan; V Strimlan; H S Ordstrand; F D Loop
Journal:  Chest       Date:  1975-07       Impact factor: 9.410

3.  Simpson catheter for percutaneous transluminal removal of atheroma.

Authors:  D E Schwarten; B T Katzen; J B Simpson; W B Cutcliff
Journal:  AJR Am J Roentgenol       Date:  1988-04       Impact factor: 3.959

4.  Obstruction of the superior vena cava.

Authors:  S K Lochridge; W P Knibbe; D B Doty
Journal:  Surgery       Date:  1979-01       Impact factor: 3.982
  4 in total
  2 in total

1.  A new use of the Simpson percutaneous atherectomy catheter: resection of retained valve cusps of an in-situ vein graft.

Authors:  J Walker; N Chalmers; I N Gillespie
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

2.  Percutaneous endovascular tissue sampling of endoluminal tumors using directional atherectomy.

Authors:  Alexander Massmann; Roland Seidel; Günther K Schneider; Arno Buecker; Peter Fries
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.